Pharmacological boosting of cGAS activation sensitizes chemotherapy by enhancing antitumor immunity-Reference-Cited by-同舟云学术

Pharmacological boosting of cGAS activation sensitizes chemotherapy by enhancing antitumor immunity

Published:2023-03 Issue:3 Volume:42 Page:112275
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Liu Haipeng^ORCID,Su Hang,Wang Fei,Dang Yifang,Ren Yijiu,Yin Shenyi,Lu Huinan,Zhang Hang,Wu Jun,Xu Zhu,Zheng Mengge,Gao Jiani,Cao Yajuan,Xu Junfang,Chen Li,Wu Xiangyang,Ma Mingtong,Xu Long,Wang Fang,Chen Jianxia,Su Chunxia,Wu Chunyan,Xie Huikang,Gu Jijie,Xi Jianzhong Jeff,Ge Baoxue,Fei Yiyan,Chen Chang

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference98 articles.

1. Association of delayed adjuvant chemotherapy with survival after lung cancer surgery;Salazar;JAMA Oncol.,2017

2. Estimates of global chemotherapy demands and corresponding physician workforce requirements for 2018 and 2040: a population-based study;Wilson;Lancet Oncol.,2019

3. Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II-IIIA (N1-N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study;Zhong;Lancet Oncol.,2018

4. Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial;Cats;Lancet Oncol.,2018

5. Cisplatin plus gemcitabine versus paclitaxel plus gemcitabine as first-line therapy for metastatic triple-negative breast cancer (CBCSG006): a randomised, open-label, multicentre, phase 3 trial;Hu;Lancet Oncol.,2015

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Schisandrin C enhances type I IFN response activation to reduce tumor growth and sensitize chemotherapy through antitumor immunity;Frontiers in Pharmacology;2024-08-07

2. Human patient derived organoids: an emerging precision medicine model for gastrointestinal cancer research;Frontiers in Cell and Developmental Biology;2024-04-04

3. Aryl hydrocarbon receptor suppresses STING-mediated type I IFN expression in triple-negative breast cancer;Scientific Reports;2024-03-08

4. cGAS: action in the nucleus;Frontiers in Immunology;2024-03-07

5. Comprehensive Analysis of Disulfidptosis-Related LncRNAs in Molecular Classification, Immune Microenvironment Characterization and Prognosis of Gastric Cancer;Biomedicines;2023-11-28